IDIX (MM)

CAMBRIDGE, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will report its financial results for the third quarter of 2008 on Thursday, October 30, 2008 after the U.S. financial markets close. In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Thursday, October 30, 2008 to discuss the company's financial results for the third quarter of 2008 and to provide an update on the company's discovery and development programs. To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 69258196 or to listen to a live audio webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. A replay of the call will also be available from 7:30 p.m. ET on October 30, 2008 until November 13, 2008 11:59 p.m. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 69258196. An archived webcast will also be available for two weeks after the call on the Idenix website. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com/. Amy Sullivan (617) 995-9901 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Amy Sullivan of Idenix Pharmaceuticals, Inc., +1-617-995-9901 Web site: http://www.idenix.com/

Copyright